Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 1/2007

01-03-2007 | Original paper

Cost of breast cancer in Sweden in 2002

Authors: Mathias Lidgren, Nils Wilking, Bengt Jönsson

Published in: The European Journal of Health Economics | Issue 1/2007

Login to get access

Abstract

Breast cancer is the most common cancer among Swedish women and an important cause of illness and death. The aim of this study was to estimate the total cost of breast cancer in Sweden in 2002, using a top-down prevalence-based cost-of-illness approach. The total cost of breast cancer in Sweden in 2002 was estimated at 3.0 billion SEK (1 € = 9.4 SEK). The direct costs were estimated at 895 million SEK and constituted 30% of the total cost. Indirect costs were estimated at 2.1 billion SEK and constituted 70% of the total cost. The main cost driver was production losses caused by premature mortality, amounting to 52% of the indirect costs. The reason that indirect costs were the dominant cost is because most newly detected breast cancers occur in patients aged below 65, thus causing significant production losses due to sick leave, early retirement, and premature mortality.
Footnotes
1
This is slightly higher than the prevalence of about 73,000 reported by previously studies. One reason for this higher figure may be that our sample includes some patients who are no longer alive, but who have not been registered as dead. However, the absolute number is small and this does not affect the estimates of the direct or indirect costs.
 
Literature
1.
The National Board of Health and Welfare: Cancer incidence in Sweden 2002. Official statistics of Sweden, Stockholm (2003)
2.
The National Board of Health and Welfare: Causes of death 2002. Official statistics of Sweden, Stockholm (2003)
3.
Olsson S., Andersson I., Karlberg I., Bjurstam N., Frodis E., Hakansson S.: Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J. Med. Screen. 7, 14–18 (2000)CrossRef
4.
Duffy S.W., Tabar L, Chen HH et al.: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95, 458–469 (2002)CrossRef
5.
Statistics Sweden: 68 Population, by age. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
6.
Statistics Sweden: 379 consumer price index (total): monthly, fixed index and calculated annual averages. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
7.
8.
Lanstingsförbundet: Kostnad per vårdtillfälle, vårddag och läkarbesök på sjukhus 2001. Lanstingsförbundet, Stockholm (2003)
9.
Lanstingsförbundet: Att mäta produktivitet i primärvården. Lanstingsförbundet, Stockholm (1999)
10.
Apoteket A.B.: Apotekens försäljning på recept 2002. Stockholm, Apoteket AB (2003)
11.
Statistics Sweden: 351 Total income from employment and business: mean averages by sex and age. Current prices. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
12.
Statistics Sweden: 339 Index numbers for direct wages for employees in the private sector, 1st quarter 1994 = 100. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
13.
Statistics Sweden: 164 Basic information and ratios for the service sector, sole proprietors excluded. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
14.
Riksförsäkringsverket: Vad kostar olika sjukdomar. Riksförsäkringsverket, Stockholm (2002)
15.
Statistics Sweden: 381 Basic amount according to the National Insurance Act. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
16.
Riksförsäkringsverket: Sjukdomar som orsakat pensionering. Riksförsäkringsverket, Stockholm (2004)
17.
Statistics Sweden: 84 Life tables. Statistical yearbook of Sweden 2004. Statistics Sweden, Stockholm (2004)
18.
Earle C.C., Chapman R.H., Baker C.S. et al.: Systematic overview of cost-utility assessments in oncology. J. Clin. Oncol. 18, 3302–3317 (2000)
19.
Lundberg L., Johannesson M., Isacson D., Borgquist L.: Health-state utilities in a general population in relation to age, gender and socioeconomic factors. Eur. J. Public Health 9, 211–217 (1999)CrossRef
20.
SIKA: Översyn av samhällsekonomiska metoder och kalkylvärden på transportområdet. SIKA, Stockholm (2002)
21.
Ekman M.: Studies in health economics: modeling and data analysis of cost and survival, Stockholm School of Economics (2002)
22.
Almbrand B., Johannesson M., Sjostrand B., Malmberg K., Ryden L.: Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur. Heart J. 21, 733–739 (2000)CrossRef
23.
Johannesson M., Meltzer D.: Some reflections on cost-effectiveness analysis. Health Econ. 7, 1–7 (1998)CrossRef
24.
Hodgson T.A., Meiners M.R.: Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem. Fund. Q. Health Soc. 60, 429–462 (1982)CrossRef
25.
Koopmanschap M.A., Rutten F.F., van Ineveld B.M., van Roijen L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14, 171–189 (1995)CrossRef
26.
Johannesson M., Karlsson G.: The friction cost method: a comment. J Health Econ 16:249–255; discussion 257–249 (1997)
27.
Statistisches Bundesamt Deutschland: Krankenheitkosten 2002. Statistisches Bundesamt Deutschland, Wiesbaden (2004)
Metadata
Title
Cost of breast cancer in Sweden in 2002
Authors
Mathias Lidgren
Nils Wilking
Bengt Jönsson
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 1/2007
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-006-0003-8

Other articles of this Issue 1/2007

The European Journal of Health Economics 1/2007 Go to the issue

Editorial

Should we really worry about “launch delays” of new drugs in OECD countries?

Original paper

Long-term absenteeism due to sickness in Sweden. How long does it take and what happens after?

Original paper

Better primary physician services lead to fewer hospital admissions

Original paper

Resource use and costs associated with patients treated for depression in primary care

Original paper

Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set

Original paper

A public–private analysis of the new Dutch health insurance system